Aging, metabolism, and Alzheimer disease: Review and hypotheses

被引:131
作者
Finch, CE
Cohen, DM
机构
[1] UNIV SO CALIF,ETHEL PERCY ANDRUS GERONTOL CTR,NEUROGERONTOL DIV,LOS ANGELES,CA 90089
[2] UNIV SO CALIF,DEPT SCI BIOL,LOS ANGELES,CA 90089
[3] UNIV SO CALIF,SCH MED,DEPT PHYSIOL & BIOPHYS,METAB RES UNIT,LOS ANGELES,CA 90033
关键词
D O I
10.1006/exnr.1996.6339
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Relationships are considered among aging, metabolism, and Alzheimer disease (AD). In particular, after 60 years, human populations show progressive age-related trends for increased blood glucose that are concurrent with the accelerating incidence of AD. The accumulation of glycated products in the AD brain, such as is also found in peripheral tissues during diabetes, suggests interactions of AD with age-related changes in metabolism. A review of 13 recent studies on AD and diabetes shows no consensus, although most studies indicate an apparent exclusion of AD and diabetes. We argue that longitudinal studies are needed to evaluate the possibility that an initial. age-related hyperglycemic state is reversed by the cachexia and weight loss common to later stages of AD. A review of literature on chronic food restriction in rodents shows the slowing of some aspects of aging in the nervous system and generally supports interactions of peripheral metabolism with brain aging. Finally, we discuss aspects of intermediary metabolism that could ensue hom oxidative damage to enzymes by glycation or oxidative stress which include excess production of ammonia hom the inhibition of glutamine synthetase and the production of glyceraldehyde-3-phosphate, a glycating agent that could contribute to damage in addition to the hyperglycemic trends during aging. (C) 1997 Academic Press
引用
收藏
页码:82 / 102
页数:21
相关论文
共 220 条
[1]
DIABETES AND THE RISK OF STROKE - THE HONOLULU-HEART-PROGRAM [J].
ABBOTT, RD ;
DONAHUE, RP ;
MACMAHON, SW ;
REED, DM ;
YANO, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (07) :949-952
[2]
Albert M. L., 1984, CLIN NEUROLOGY AGING, P53
[3]
STROKE IN THE DIABETIC PATIENT [J].
BELL, DSH .
DIABETES CARE, 1994, 17 (03) :213-219
[4]
TOWARD PHYSIOLOGICAL UNDERSTANDING OF GLUCOSE-TOLERANCE - MINIMAL-MODEL APPROACH [J].
BERGMAN, RN .
DIABETES, 1989, 38 (12) :1512-1527
[5]
BERGMAN RN, 1990, BIOMEDICAL ADV AGING
[6]
MONOKINE SECRETION IN AGING AND PROTEIN-MALNUTRITION [J].
BRADLEY, SF ;
VIBHAGOOL, A ;
KUNKEL, SL ;
KAUFFMAN, CA .
JOURNAL OF LEUKOCYTE BIOLOGY, 1989, 45 (06) :510-514
[7]
DIABETIC NEUROPATHY, NERVE GROWTH-FACTOR AND OTHER NEUROTROPHIC FACTORS [J].
BREWSTER, WJ ;
FERNYHOUGH, P ;
DIEMEL, LT ;
MOHIUDDIN, L ;
TOMLINSON, DR .
TRENDS IN NEUROSCIENCES, 1994, 17 (08) :321-325
[8]
A CASE-CONTROL STUDY OF ALZHEIMERS-DISEASE IN AUSTRALIA [J].
BROE, GA ;
HENDERSON, AS ;
CREASEY, H ;
MCCUSKER, E ;
KORTEN, AE ;
JORM, AF ;
LONGLEY, W ;
ANTHONY, JC .
NEUROLOGY, 1990, 40 (11) :1698-1707
[9]
BRONSON RT, 1990, GENETIC EFFECTS AGIN, V2
[10]
SYNAPSE LOSS AND GLIOSIS IN THE MOLECULAR LAYER OF THE CEREBRAL-CORTEX IN ALZHEIMERS-DISEASE AND IN FRONTAL-LOBE DEGENERATION [J].
BRUN, A ;
LIU, XY ;
ERIKSON, C .
NEURODEGENERATION, 1995, 4 (02) :171-177